Genoskin appointed CSO

Gaudenzio is world-renowned as researcher and expert in immunology and allergic skin inflammation, principal investor and the leader of research group at the Toulouse Institute for Infectious and Inflammatory Diseases (F), established in January 2021.

He will structure and lead Genoskin’s R&D team in immunology and data-oriented innovations, supporting the development of new offers and establishing the company’s long-term scientific strategy. He knows the biotechnology company well because he worked there as a senior consultant since the end of 2019. Genoskin was founded in 2011 as spin-off of the French National Center for Scientific Research and the Paul Sabatier University in Toulouse.